Lumason is a Intravenous; Intravesical Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Distearoylphosphatidylcholine, Dl-; Sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol); Sulfur Hexafluoride.
Product ID | 0270-7097_0730c3bf-1564-4cb0-88ce-430be8b835f0 |
NDC | 0270-7097 |
Product Type | Human Prescription Drug |
Proprietary Name | Lumason |
Generic Name | Sulfur Hexafluoride |
Dosage Form | Injection, Powder, Lyophilized, For Suspension |
Route of Administration | INTRAVENOUS; INTRAVESICAL |
Marketing Start Date | 2021-04-01 |
Marketing Category | NDA / |
Application Number | NDA203684 |
Labeler Name | BRACCO DIAGNOSTICS INC |
Substance Name | DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE |
Active Ingredient Strength | 0 mg/mg; mg/mg; mg/mg |
Pharm Classes | Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-04-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0270-7097 | Lumason | SULFUR HEXAFLUORIDE |
0270-7099 | LumaSon | SULFUR HEXAFLUORIDE |
68155-099 | LumaSon | SULFUR HEXAFLUORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LUMASON 88284789 5834181 Live/Registered |
Bracco Diagnostics Inc. 2019-01-31 |
LUMASON 85929727 4786320 Live/Registered |
Bracco Diagnostics Inc. 2013-05-13 |